Open federal opportunities

Epinephrine Injector

DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT · Response deadline: Mon, 30 Nov 2026

What the government is buying

The Defense Logistics Agency (DLA) Troop Support, Medical division is soliciting offers for epinephrine injectors. These medical devices deliver a measured dose of epinephrine to treat severe allergic reactions (anaphylaxis). DLA Troop Support manages medical supply chains for the U.S. military and other authorized federal customers, which typically includes stocking emergency medications for field hospitals, clinics, and operational medical kits.

Epinephrine injectors are a critical shortage item requiring careful temperature-controlled storage and handling, with specific manufacturer certifications and FDA compliance for automated drug delivery devices.

Key facts

NAICS 325412 corresponds to Pharmaceutical Preparation Manufacturing, which includes manufacturers of medicinal and botanical products. No small business set-aside applies, meaning businesses of all sizes may compete.

Who can bid

This solicitation is open to all responsible offerors regardless of size. Because no set-aside applies, large pharmaceutical manufacturers, mid-size firms, and small businesses may submit offers. However, given the specialized nature of FDA-regulated pharmaceutical manufacturing, potential bidders should realistically assess their capabilities:

• Direct manufacturers with FDA-approved epinephrine auto-injector products and current good manufacturing practice (cGMP) compliance
• Authorized distributors with established supply agreements with FDA-approved manufacturers, if the solicitation permits non-manufacturer bids
• Small pharmaceutical firms with relevant FDA approvals and sufficient production capacity for federal contract volumes

See the solicitation for specific eligibility requirements, including any restrictions on foreign products under the Buy American Act or Trade Agreements Act.

How to put together a competitive bid

For unrestricted pharmaceutical supply contracts, focus on these elements:

Regulatory documentation: Ensure your FDA approval, NDA/ANDA status, and cGMP inspection records are current and organized for submission. Government medical procurements require extensive pharmaceutical quality verification.

Technical compliance against specifications: Epinephrine injectors have precise dosage requirements, shelf-life specifications, and device reliability standards. See the solicitation for exact product specifications—do not assume requirements match commercial products.

Pricing strategy with lifecycle cost analysis: Include not just unit pricing but storage, handling, cold-chain logistics, and any shelf-life rotation requirements. Government pharmaceutical contracts often evaluate total delivered cost.

Supply chain resilience: Demonstrate manufacturing capacity, backup production capabilities, and surge capacity. DLA prioritizes reliable delivery of critical medical items to military operations worldwide.

Past performance evidence: Document comparable federal or commercial contracts for pharmaceutical products, particularly emergency medications or controlled-temperature items.

Small business participation (if subcontracting): Even without a set-aside, prime contractors may strengthen proposals by including small business subcontracting plans.

Next steps

Read the full solicitation on SAM.gov using solicitation number SPE2D2-26-R-0009. Verify all product specifications, delivery requirements, and evaluation criteria before preparing your offer. Note the firm deadline of November 30, 2026 at 3:00 PM Eastern Time—late submissions will not be considered. Given the complexity of pharmaceutical government contracting, allow adequate time for internal review and any required SAM.gov registrations or certifications.

View the official notice on SAM.gov →